The risk of addiction among physicians - Are we anaesthesiologists particulary vulnerable?;Das Suchtrisiko bei Medizinern

Anasthesiologie und Intensivmedizin

Volumn 50, Issue 5, 2009, Pages 286-295

  Soukup, J ^a   Schmale, M ^a  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

Anaesthesiologists; Drug addiction; Physicians

Indexed keywords

ALCOHOL; BENZODIAZEPINE; NICOTINE;

ANESTHESIST; CLINICAL PRACTICE; DRUG DEPENDENCE; HEALTH CARE POLICY; HUMAN; INTENSIVE CARE; MEDICAL PERSONNEL; MEDICINE; PHYSICIAN; POPULATION; PREVALENCE; REVIEW; RISK ASSESSMENT; TABOO;

EID: 67049118942     PISSN: 01705334     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Alexander BH, Checkoway H, Nagahama SI, Domino KB. Cause-specific mortality risks of anesthesiologists. Anesthesiology 2000;93(4):922-930.
2. American Medical Association: The sick physician, impairment by psychiatric disorders, including alcoholism and drug dependence. J Am Med Ass 1973;233:684-687.
3. Beaujouan L, Czernichow S, Pourriat JL, Bonnet F. [Prevalence and risk factors for substance abuse and dependence among anaesthetists: a national survey] Ann Fr Anesth Reanim 2005;24(5):471-479.
4. Boening JA. Neurobiology of an addiction memory. J Neural Transm 2001;108(6):755-765.
5. Brewster JM. Drug Use Among Canadian Professionals - Executive Summary of Final Report. Minister of Supply and Services, Canada; 1994.
6. Centrella M. Physician addiction and impairment - current thinking: a review. J addict Dis 1994;13:1-31.
7. Collins GB, McAllister MS, Jensen M, Gooden TA. Chemical dependency treatment outcomes of residents in anesthesiology: results of a survey. Anesth Analg 2005;101(5):1457-1462.
8. Cornette MM, deRoon-Cassini TA, Fosco GM, Holloway RL, Clark DC, Joiner TE. Application of an interpersonal-psychological model of suicidal behavior to physicians and medical trainees. Arch Suicide Res 2009;13(1):1-14.
9. Di Chiara G. Psychobiology of the role of dopamine in drug- abuse and addiction. Neuroscience Research Communications 1995;17(2):133-143.
10. Domenighetti, G. Psychoactive drug use among medical doctors is higher than in the general population. Soc Sci Med 1991;33:269-274.
11. Domino KB, Hornbein TF, Polissar NL, Renner G, Johnson J, Alberti S, et al. Risk factors for relapse in health care professionals with substance use disorders. JAMA 2005;293(12):1453- 1460.
12. Farley WJ, Talbott GD. Anesthesiology and addiction. Anesth Analg 1983;62(5):465-466.
13. Feuerlein, W. Alkoholprobleme des Arztes. Munch med Wschr 1986;128:385-388.
14. FDA Drug Bull 1979;5(9):24.
15. Follette JW, Farley WJ. Anesthesiologist addicted to propo- fol. Anesthesiology 1992;77(4):817-818.
16. Gallegos KV, Browne CH, Veit FW, Talbott GD. Addiction in anesthesiologists: drug access and patterns of substance abuse. QRB Qual Rev Bull 1988;14(4):116-122.
17. Glaeske. Psychotrope und andere Arzneimittel mit Missbrauchs- und Abhängigkeitspotential. Jahrbuch Sucht 2004. Neuland; 2003.
18. Gold MS, Byars JA, Frost-Pineda K. Occupational exposure and addictions for physicians: case studies and theoretical implications. Psychiatr Clin North Am 2004;27(4):745-753.
19. Grant IS, Mackenzie N. Recovery following propofol ('Diprivan') anaesthesia-a review of three different anaesthetic techniques. Postgrad Med J 1985;61(Suppl 3):133-137.
20. Gravenstein JS, Kory WP, Marks RG. Drug abuse by anesthesia personnel. Anesth Analg 1983;62(5):467-472.
21. Hughes PH, Brandenburg N, Baldwin DC, Storr L, et al. Prevalence of substance use among US physicians. J Am Med Ass 1992;267:2333-2339.
22. Iwersen-Bergmann S, Rosner P, Kuhnau HC, Junge M, Schmoldt A. Death after excessive propofol abuse. Int J Legal Med 2001 ;114(4-5):248-251.
23. Kielholz P, Ladewig D. Die Abhängigkeit von Drogen. Miïnchen: Dtv; 1973.
24. Koob GF, Nestler EJ. The neurobiology of drug addiction. J Neuropsychiat Clin Neurosci 1997;9:482-497.
25. rd", Geer RT, Ominsky AJ, Gross J, et al. A departmental policy addressing chemical substance abuse. Anesthesiology 1986;65(4):414-417.
26. Levine B, Cox D, Jufer-Phipps RA, Li L, Jacobs A, Fowler D. A fatality from sevoflurane abuse. J Anal Toxicol 2007;31(8):534-536.
27. Lloyd, G. Alcoholic doctors can recover. Brit Med J 1990;300:728-730.
28. Mann K, Buchkremer G (Hrsg.) Sucht. Grundlagen, Diagnostik, Therapie. Stuttgart: Fischer; 1996.
29. Maulen B, Gottschaldt M, Feuerlein W, Bonitz G. Abhängigkeit bei Ärzten - Eine klinische Studie zu Betroffenen in der Bundesrepublik Deutschland. Miïnch med Wschr 1991;133: 446-449.
30. Maulen, B. Die Oberberg-Kliniken für psychosomatische Medizin. Krankenhauspsychiatrie 1994;5:46-47.
31. Mäulen B, Gottschaldt M, Damm K. Hilfsmoglichkeiten für abhängige Ärzte - Unterstützung durch die Ärztekammern. Dtsch Ärztebl 1995;47:3305-3306.
32. Maulen B. Gute Therapieerfolge bei abhängigen Ärzten. Kassenarzt 1996;36:48-52.
33. Noble EP. Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review. Eur Psychiatry 2000;15:79-89.
34. Payk T. Psychiater - Forscher im Labyrinth der Seele. Stuttgart: Kohlhammer Verlag; 2000.
35. Reimer C, Trinkaus S, Jurkat HB. Suizidalität bei Arztinnen und Ärzten. Psychiatr Prax 2005;32(8):381-385.
36. Roussin A, Montastruc JL, Lapeyre-Mestre M. Pharmacological and clinical evidences on the potential for abuse and dependence of propofol: a review of the literature. Fundam Clin Pharmacol 2007;21(5):459-466.
37. Schernhammer ES, Colditz GA. Suicide rates among physicians: a quantitative and gender assessment (meta-analysis). Am J Psychiatry 2004;161(12):2295-2302.
38. Siegel RK. Phencyclidine and ketamine intoxication: a study of four populations of recreational users. NIDA Res Monogr 1978; 21:119-147.
39. Silverman M. Physicians and Suicide. In: Goldman L (ed.) The Handbook of physician Health. Chicago: American Medical Association; 2000.
40. Shapiro CS, Fluharty DG. Relapse factors in chemically dependent female physiciens. J int Conf Phys Health Abstracts Arizona 1996: 247.
41. Talbott GD, Gallegos KV, Wilson P0. The Medical Association of Georgia's Impaired Physicians Program - review of the first 1,000 physicians. J Amer Med Ass 1987;25:2927-2930.
42. Unger HL, Huppmann G. Suchtkranke Ärzte - Eine Heraus- forderung für ihren Berufsstand. Psycho 1990;16:7-11.
43. Walker DJ, Beckman NJ, Zacny JP. Reinforcing and subjective effects of the volatile anesthetic, sevoflurane. Drug Alcohol Depend 2004;76(2):191-201.
44. Walton R, Johnstone E, Munafò M, Neville M, Griffiths S. Genetic clues to the molecular basis of tobacco addiction and progress towards personalized therapy. Trends Mol Med 2001 ;7:70-76.
45. Wanke K. 1st Alkoholismus eine Art Berufskrankheit bei Medizinern? Psycho 1990;16:3-4.
46. Wilson JE, Kiselanova N, Stevens Q, Lutz R, Mandler T, Tran ZV, et al. A survey of inhalational anaesthetic abuse in anaesthesia training programmes. Anaesthesia 2008;63(6):616-620.
47. Wischmeyer PE, Johnson BR, Wilson JE, Dingmann C, Bachman HM, Roller E, et al. A survey of propofol abuse in academic anesthesia programs. Anesth Analg 2007;105(4):1066- 1071.
48. Zacny JP, Lichtor JL, Thompson W, Apfelbaum JL. Propofol at a subanesthetic dose may have abuse potential in healthy volunteers. Anesth Analg 1993;77(3):544-552 .